Aims: The effect of the COVID-19 pandemic on care and outcomes across non-COVID-19 cardiovascular (CV) diseases is unknown. A systematic review and meta-Analysis was performed to quantify the effect and investigate for variation by CV disease, geographic region, country income classification and the time course of the pandemic. Methods and results: From January 2019 to December 2021, Medline and Embase databases were searched for observational studies comparing a pandemic and pre-pandemic period with relation to CV disease hospitalisations, diagnostic and interventional procedures, outpatient consultations, and mortality. Observational data were synthesised by incidence rate ratios (IRR) and risk ratios (RR) for binary outcomes and weighted mean differences for continuous outcomes with 95% confidence intervals. The study was registered with PROSPERO (CRD42021265930). A total of 158 studies, covering 49 countries and 6 continents, were used for quantitative synthesis. Most studies (80%) reported information for high-income countries (HICs). Across all CV disease and geographies there were fewer hospitalisations, diagnostic and interventional procedures, and outpatient consultations during the pandemic. By meta-regression, in low-middle income countries (LMICs) compared to HICs the decline in ST-segment elevation myocardial infarction (STEMI) hospitalisations (RR 0.79, 95% confidence interval [CI] 0.66-0.94) and revascularisation (RR 0.73, 95% CI 0.62-0.87) was more severe. In LMICs, but not HICs, in-hospital mortality increased for STEMI (RR 1.22, 95% CI 1.10-1.37) and heart failure (RR 1.08, 95% CI 1.04-1.12). The magnitude of decline in hospitalisations for CV diseases did not differ between the first and second wave. Conclusions: There was substantial global collateral CV damage during the COVID-19 pandemic with disparity in severity by country income classification.

The collateral damage of COVID-19 to cardiovascular services. A meta-Analysis / Nadarajah, R.; Wu, J.; Hurdus, B.; Asma, S.; Bhatt, D. L.; Biondi-Zoccai, G.; Mehta, L. S.; Ram, C. V. S.; Ribeiro, A. L. P.; Van Spall, H. G. C.; Deanfield, J. E.; Luscher, T. F.; Mamas, M.; Gale, C. P.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 43:33(2022), pp. 3164-3178. [10.1093/eurheartj/ehac227]

The collateral damage of COVID-19 to cardiovascular services. A meta-Analysis

Biondi-Zoccai G.;
2022

Abstract

Aims: The effect of the COVID-19 pandemic on care and outcomes across non-COVID-19 cardiovascular (CV) diseases is unknown. A systematic review and meta-Analysis was performed to quantify the effect and investigate for variation by CV disease, geographic region, country income classification and the time course of the pandemic. Methods and results: From January 2019 to December 2021, Medline and Embase databases were searched for observational studies comparing a pandemic and pre-pandemic period with relation to CV disease hospitalisations, diagnostic and interventional procedures, outpatient consultations, and mortality. Observational data were synthesised by incidence rate ratios (IRR) and risk ratios (RR) for binary outcomes and weighted mean differences for continuous outcomes with 95% confidence intervals. The study was registered with PROSPERO (CRD42021265930). A total of 158 studies, covering 49 countries and 6 continents, were used for quantitative synthesis. Most studies (80%) reported information for high-income countries (HICs). Across all CV disease and geographies there were fewer hospitalisations, diagnostic and interventional procedures, and outpatient consultations during the pandemic. By meta-regression, in low-middle income countries (LMICs) compared to HICs the decline in ST-segment elevation myocardial infarction (STEMI) hospitalisations (RR 0.79, 95% confidence interval [CI] 0.66-0.94) and revascularisation (RR 0.73, 95% CI 0.62-0.87) was more severe. In LMICs, but not HICs, in-hospital mortality increased for STEMI (RR 1.22, 95% CI 1.10-1.37) and heart failure (RR 1.08, 95% CI 1.04-1.12). The magnitude of decline in hospitalisations for CV diseases did not differ between the first and second wave. Conclusions: There was substantial global collateral CV damage during the COVID-19 pandemic with disparity in severity by country income classification.
2022
cardiovascular; COVID-19; hospitalization; mortality; treatment
01 Pubblicazione su rivista::01a Articolo in rivista
The collateral damage of COVID-19 to cardiovascular services. A meta-Analysis / Nadarajah, R.; Wu, J.; Hurdus, B.; Asma, S.; Bhatt, D. L.; Biondi-Zoccai, G.; Mehta, L. S.; Ram, C. V. S.; Ribeiro, A. L. P.; Van Spall, H. G. C.; Deanfield, J. E.; Luscher, T. F.; Mamas, M.; Gale, C. P.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 43:33(2022), pp. 3164-3178. [10.1093/eurheartj/ehac227]
File allegati a questo prodotto
File Dimensione Formato  
Nadarajah_Collateral-damage_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.18 MB
Formato Adobe PDF
2.18 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1678370
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 30
social impact